Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	73
Overall Study	STARTED	TAK-906 Maleate 5 mg	23
Overall Study	STARTED	TAK-906 Maleate 25 mg	72
Overall Study	STARTED	TAK-906 Maleate 50 mg	74
Overall Study	COMPLETED	Placebo	67
Overall Study	COMPLETED	TAK-906 Maleate 5 mg	21
Overall Study	COMPLETED	TAK-906 Maleate 25 mg	67
Overall Study	COMPLETED	TAK-906 Maleate 50 mg	72
Overall Study	NOT COMPLETED	Placebo	6
Overall Study	NOT COMPLETED	TAK-906 Maleate 5 mg	2
Overall Study	NOT COMPLETED	TAK-906 Maleate 25 mg	5
Overall Study	NOT COMPLETED	TAK-906 Maleate 50 mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03544229/flow